Total Addressable Market (TAM)

What is total addressable market?

Total addressable market (TAM) is a sizing estimate: the revenue ceiling for an offering if every customer who could plausibly use it did so, at the expected price. It is expressed as an annual dollar figure, sometimes alongside a unit count such as patients, procedures, prescriptions or facilities.

TAM is usually paired with two narrower measures. Serviceable addressable market (SAM) is the share of TAM a company can actually reach with its current product, channels, geography and regulatory clearances. Serviceable obtainable market (SOM) is the share it can realistically win in a set period against competitors.

In healthcare the customer and the payer are often different parties. A drug's TAM depends on patients, prescribers and payer coverage together, while software sold to hospitals may be sized by facilities, beds or clinicians rather than by patients.

How TAM is calculated

Analysts use three main approaches and often run more than one to check the result:

• Top-down: start from a published total, such as disease prevalence or national spending in a category, narrow it by the share of patients diagnosed, treated and eligible, then multiply by an expected annual price.
• Bottom-up: count the actual buyers or users, such as physicians in a specialty, hospitals performing a procedure or pharmacies dispensing a drug class, and multiply by expected volume and price per buyer.
• Value-based: estimate the costs a product avoids or the outcomes it improves, then assume a price that captures part of that value. This is common for new therapies and devices without direct comparators.

Why TAM matters in healthcare

Investors, private equity analysts and corporate development teams use TAM to judge whether a market is large enough to justify a launch, an acquisition or a new sales territory. Commercial teams use it to set targets and allocate field resources across specialties and regions.

A bottom-up TAM built from public data is easier to defend than a top-down figure borrowed from a report. Provider counts by specialty from the National Plan and Provider Enumeration System (NPPES), procedure counts from Medicare Physician and Other Practitioners data and prescription counts from Medicare Part D Prescriber data give checkable inputs, although each covers only part of the market.

Common TAM mistakes

Common errors inflate TAM far more often than they shrink it:

• Counting prevalence as demand: many people with a condition are undiagnosed, untreated or treated with cheaper options.
• Using list price: net prices after rebates, discounts and patient assistance can be far lower than list or wholesale prices.
• Ignoring access limits: payer coverage rules, prior authorization and site-of-care requirements shrink the reachable market.
• Scaling Medicare data to the whole population: Medicare claims reflect an older population and exclude most commercial and Medicaid patients.